Canada animal vaccine market is estimated to grow at a CAGR of around 7.8% during the forecast period. The major factors contributing to the growth of the market include the increasing adoption of pets among households. As per the Food and Agriculture Organization of the United Nations (FAO), the production of chickens in Canada was 170,442, per 1000 head in 2017 and 170,106, per 1000 head in 2016. This growth in chickens results in the emerging focus on proper health of poultry birds, which in turn, is promoting the growth of the market in Canada.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/canada-animal-vaccine-market
Moreover, Canadian pet health regulatory norms are such that a person needs to keep a health certificate to carry the pet outside Canada. It ensures compulsory vaccination for the pets. This is expected to further promote the demand for animal vaccines in Canada, thereby promoting the growth of the market in the near future. The growing awareness among people regarding animal health is encouraging the demand for animal vaccines in the country.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/canada-animal-vaccine-market
Some crucial players in the Canada animal vaccine market include Zoetis, Inc., Elanco, Merck & Co., Inc., Novartis International AG and Vetoquinol SA. To survive in the market, these players are adopting crucial strategies, such as mergers and acquisitions, product launches, and partnerships and collaborations. This enables the company to increase its competitiveness and attract significant share in the market. For instance, in December 2019, Vétoquinol acquired animal health business assets of VETCOM 1979 INC. The VETCOM 1979 INC. animal health business comprises annual revenue of nearly $1.1 million. This will enable Vétoquinol to reinforce their presence in Canada in the companion animal market.
Market Segmentation
Canada Animal Vaccine Market by Type
- Porcine Vaccines
- Poultry Vaccines
- Livestock Vaccines
- Aquaculture Vaccines
- Companion Animal Vaccines
- Other Animal Vaccines
Canada Animal Vaccine Market by Technology
- Live Attenuated Vaccine
- Killed/Inactive Vaccine
- Recombinant Vaccine
- Vectored Vaccine
- Subunit Vaccine
- DNA Vaccine
- Chimeric Vaccine
- Others
Company Profiles
- Bimeda Holdings PLC
- Boehringer Ingelheim International GmbH
- Elanco
- Merck & Co., Inc.
- Neogen Corp.
- Novartis International AG
- VBI Vaccines Inc.
- Vetoquinol SA
- Virbac SA
- Zoetis, Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
